Acceptability of a Randomized Trial of Anti-depressant Medication or Interpersonal Therapy for Treatment of Perinatal Depression in Women with HIV

AIDS Behav. 2024 Apr;28(4):1123-1136. doi: 10.1007/s10461-023-04264-0. Epub 2024 Feb 14.

Abstract

Postpartum depression (PPD) affects nearly 20% of postpartum women in Sub-Saharan Africa (SSA), where HIV prevalence is high. Depression is associated with worse HIV outcomes in non-pregnant adults and mental health disorders may worsen HIV outcomes for postpartum women and their infants. PPD is effectively treated with psychosocial or pharmacologic interventions; however, few studies have evaluated the acceptability of treatment modalities in SSA. We analyzed interviews with 23 postpartum women with HIV to assess the acceptability of two depression treatments provided in the context of a randomized trial. Most participants expressed acceptability of treatment randomization and study visit procedures. Participants shared perceptions of high treatment efficacy of their assigned intervention. They reported ongoing HIV and mental health stigma in their communities and emphasized the importance of social support from clinic staff. Our findings suggest a full-scale trial of PPD treatment will be acceptable among women with HIV in Zambia.

Keywords: Antidepressant medication; Depression; HIV; Interpersonal therapy; Low resource setting; Zambia.

MeSH terms

  • Adult
  • Depression / therapy
  • Depression, Postpartum* / epidemiology
  • Depressive Disorder* / complications
  • Female
  • HIV Infections* / complications
  • HIV Infections* / epidemiology
  • HIV Infections* / psychology
  • Humans
  • Postpartum Period
  • Pregnancy
  • Randomized Controlled Trials as Topic
  • Treatment Outcome